Amanta Healthcare IPO: Sterile Injectable Maker Oversubscribed 41 Times So Far, Check GMP And Other Key Details

Amanta Healthcare IPO (Amanta Healthcare Ltd) is scheduled to close on September 3. Investors have booked the Amanta Healthcare IPO more than 41 times within the three days of bidding. The sterile injectable maker's issue has received bids for over 291.05 million shares so far against the 7 million shares offered for subscription.

Amanta Healthcare IPO GMP

Amanta Healthcare shares are commanding a grey market premium (GMP) ranging between Rs 10 and Rs 13 per share according to websites which monitor the movement of unlisted shares. Given the GMP of Rs 13, Amanta Healthcare shares are likely to make a strong debut with a premium of 10.31 per cent at Rs 139 per share.

Amanta Healthcare IPO: Subscription On Day 3

Non-Institutional Investors are driving the demand for Amanta Healthcare shares as the issue has been booked 103.6 times in the NII category so far. NII's have placed bids for 155.29 million shares of the sterile injectable maker against the 1.5 million shares reserved for subscription. Amanta Healthcare's IPO has been booked 38.21 times by retail individual investors (RIIs) so far. RIIs placed bids for 133.7 million shares compared to the 3.5 million shares reserved for the retail category. Qualified Institutional Buyers (QIBs) have applied for 1.92 million shares of the sterile injectable maker so far on the last day of bidding against the 2 million shares reserved for the category, booking the issue at 96 per cent.

Amanta Healthcare IPO: Offer Size and Price Band

Amanta Healthcare Ltd is worth Rs 126 crore. The public issue consists of a fresh issuance of 10 million shares. Amanta Healthcare IPO price band was set at Rs 120 to Rs 126 per share. RIIs can bid for Amanta Healthcare IPO by placing bids for a minimum of 119 shares, which aggregates to an investment of Rs 14,994.

Amanta Healthcare IPO: Subscription window, listing date, allotment date

Amanta Healthcare IPO opened for subscription on September 1. Amanta Healthcare IPO bidding window is scheduled to close on September 3. The share allotment status of Amanta Healthcare IPO will be announced on September 4. Subsequently, the medical devices manufacturer will issue refunds for unsuccessful applicants on September 8.  Amanta Healthcare Ltd shares are scheduled to list on the bourses on September 9.

Amanta Healthcare: Financials

Amanta Healthcare's total income for FY25 declined to Rs 276.09 crore, slipping by nearly 2 per cent from Rs 281.61 crore in FY24. The sterile injectable company's profit-after-tax increased by nearly 190 per cent to Rs 10.5 crore in FY25 compared to Rs 3.63 crore in the preceding fiscal.

Amanta Healthcare IPO: Registrar

MUFG Intime India Pvt Ltd is the registrar for Amanta Healthcare IPO andBeeline Capital Advisors Pvt.Ltd is the book-running lead manager for the issue.

Amanta Healthcare: Promoters

Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Ltd are among the promoters of the sterile injectable manufacturer. The promoters of the company will reduce their stake from 85.6 per cent to 63.56 per cent once the issue concludes.

Amanta Healthcare IPO: Objective

Amanta Healthcare will use the funds generated through the public issue for its capital expenditure needs and for general corporate purposes.

About Amanta Healthcare Ltd

Amanta Healthcare Ltd  has a specialisation in development, manufacturing, and marketing of sterile liquid products and medical devices.